Status:
TERMINATED
A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Pain, Postoperative
Eligibility:
MALE
18-45 years
Phase:
PHASE2
Brief Summary
This study is being conducted to evaluate the safety and tolerability of the drug and to evaluate its efficacy compared to placebo and to ibuprofen in the prevention of postoperative dental pain in ma...
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Patients in generally good health who are scheduled to have 2 or more third molars removed, at least 1 of which is partially or completely embedded in bone and is a mandibular impaction
- Exclusion Criteria :
- Patient has a history of any illness or condition that, in the opinion of the investigator, might confound the results of the study or pose additional risk to the patient
Exclusion
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2007
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00424424
Start Date
August 1 2006
End Date
January 1 2007
Last Update
November 2 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.